These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 29705091)

  • 1. Albuminuric and non-albuminuric chronic kidney disease in type 1 diabetes: Association with major vascular outcomes risk and all-cause mortality.
    Garofolo M; Russo E; Miccoli R; Lucchesi D; Giusti L; Sancho-Bornez V; Daniele G; Del Prato S; Penno G
    J Diabetes Complications; 2018 Jun; 32(6):550-557. PubMed ID: 29705091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes.
    Buyadaa O; Magliano DJ; Salim A; Koye DN; Shaw JE
    Diabetes Care; 2020 Jan; 43(1):122-129. PubMed ID: 31796570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study.
    Penno G; Solini A; Orsi E; Bonora E; Fondelli C; Trevisan R; Vedovato M; Cavalot F; Lamacchia O; Scardapane M; Nicolucci A; Pugliese G;
    Diabetologia; 2018 Nov; 61(11):2277-2289. PubMed ID: 30032426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus.
    Penno G; Russo E; Garofolo M; Daniele G; Lucchesi D; Giusti L; Sancho Bornez V; Bianchi C; Dardano A; Miccoli R; Del Prato S
    Diabetologia; 2017 Jun; 60(6):1102-1113. PubMed ID: 28357502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and all-cause mortality in patients with type 2 diabetes mellitus in the MADIABETES Cohort Study: Association with chronic kidney disease.
    Salinero-Fort MÁ; San Andrés-Rebollo FJ; de Burgos-Lunar C; Abánades-Herranz JC; Carrillo-de-Santa-Pau E; Chico-Moraleja RM; Jiménez-García R; López-de-Andrés A; Gómez-Campelo P;
    J Diabetes Complications; 2016 Mar; 30(2):227-36. PubMed ID: 26627635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study.
    Penno G; Solini A; Bonora E; Orsi E; Fondelli C; Zerbini G; Trevisan R; Vedovato M; Cavalot F; Laviola L; Nicolucci A; Pugliese G;
    Acta Diabetol; 2018 Jun; 55(6):603-612. PubMed ID: 29574497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of macro- and microvascular complications in patients with type 2 diabetes and kidney disease with or without albuminuria in a single Chinese Diabetes Centre.
    Wu D; Xuan Y; Ruan Y; Feng X; Zhu Y; Jia C; Liu J; Li H; Li L; Dong X
    Diab Vasc Dis Res; 2016 Jan; 13(1):21-30. PubMed ID: 26499917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes.
    Viazzi F; Piscitelli P; Giorda C; Ceriello A; Genovese S; Russo GT; Fioretto P; Guida P; De Cosmo S; Pontremoli R;
    J Diabetes Complications; 2017 Feb; 31(2):419-426. PubMed ID: 27884661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between albuminuric CKD and diabetic retinopathy in a real-world setting of type 2 diabetes: Findings from No blind study.
    Sasso FC; Pafundi PC; Gelso A; Bono V; Costagliola C; Marfella R; Sardu C; Rinaldi L; Galiero R; Acierno C; Caturano A; de Sio C; De Nicola L; Salvatore T; Nevola R; Adinolfi LE; Minutolo R;
    Nutr Metab Cardiovasc Dis; 2019 Sep; 29(9):923-930. PubMed ID: 31377186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.
    Rotbain Curovic V; Theilade S; Winther SA; Tofte N; Eugen-Olsen J; Persson F; Hansen TW; Jeppesen J; Rossing P
    Diabetes Care; 2019 Jun; 42(6):1112-1119. PubMed ID: 30885954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 diabetes albuminuric and non-albuminuric phenotypes have different morphological and functional ultrasound features of diabetic kidney disease.
    Garofolo M; Napoli V; Lucchesi D; Accogli S; Mazzeo ML; Rossi P; Neri E; Del Prato S; Penno G
    Diabetes Metab Res Rev; 2023 Jan; 39(1):e3585. PubMed ID: 36273390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney outcomes and all-cause mortality in people with type 2 diabetes exhibiting non-albuminuric kidney insufficiency.
    Yamamoto Y; Hanai K; Mori T; Yokoyama Y; Yoshida N; Murata H; Shinozaki T; Babazono T
    Diabetologia; 2022 Jan; 65(1):234-245. PubMed ID: 34739552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albuminuric and non-albuminuric reduced eGFR phenotypes in youth with type 1 diabetes: Factors associated with cardiometabolic risk.
    Di Bonito P; Mozzillo E; Rosanio FM; Maltoni G; Piona CA; Franceschi R; Ripoli C; Ricciardi MR; Tornese G; Arnaldi C; Iovane B; Iafusco D; Zanfardino A; Suprani T; Savastio S; Cherubini V; Tiberi V; Piccinno E; Schiaffini R; Delvecchio M; Casertano A; Maffeis C; Franzese A;
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(7):2033-2041. PubMed ID: 34083127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of mortality and cardiovascular disease risks with diabetes and albuminuria in urban Indigenous Australians: the DRUID follow-up study.
    Barr ELM; Cunningham J; Tatipata S; Dunbar T; Kangaharan N; Guthridge S; Li SQ; Condon JR; Shaw JE; O'Dea K; Maple-Brown LJ
    Diabet Med; 2017 Jul; 34(7):946-957. PubMed ID: 28375555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HbA1c variability as an independent correlate of nephropathy, but not retinopathy, in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study.
    Penno G; Solini A; Bonora E; Fondelli C; Orsi E; Zerbini G; Morano S; Cavalot F; Lamacchia O; Laviola L; Nicolucci A; Pugliese G;
    Diabetes Care; 2013 Aug; 36(8):2301-10. PubMed ID: 23491522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial Stiffness Predicts Mortality in Individuals With Type 1 Diabetes.
    Tynjälä A; Forsblom C; Harjutsalo V; Groop PH; Gordin D;
    Diabetes Care; 2020 Sep; 43(9):2266-2271. PubMed ID: 32647049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease.
    Charytan DM; Solomon SD; Ivanovich P; Remuzzi G; Cooper ME; McGill JB; Parving HH; Parfrey P; Singh AK; Burdmann EA; Levey AS; Eckardt KU; McMurray JJV; Weinrauch LA; Liu J; Claggett B; Lewis EF; Pfeffer MA
    Diabetes Obes Metab; 2019 May; 21(5):1199-1208. PubMed ID: 30672083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral arterial endothelial dysfunction predicts future cardiovascular events in diabetic patients with albuminuria: a prospective cohort study.
    Koo BK; Chung WY; Moon MK
    Cardiovasc Diabetol; 2020 Jun; 19(1):82. PubMed ID: 32534580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild to moderate chronic kidney disease and cardiovascular events in patients with type 2 diabetes mellitus.
    Lessey G; Stavropoulos K; Papademetriou V
    Vasc Health Risk Manag; 2019; 15():365-373. PubMed ID: 31686830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.